by adminAdrianRamirez | Feb 3, 2017 | Axim Biotechnologies, Company News, Media Coverage, Scientific Research
[vc_row][vc_column][vc_column_text]CanChew® Plus and AXIM® Biotechnologies were part of a news segment this week on CBS New York regarding the company’s ongoing clinical trials for the use of its patented CanChew® Plus CBD gum for the treatment of irritable bowel...
by adminAdrianRamirez | Jan 27, 2017 | Axim Biotechnologies, Company News, HempMeds Brasil, HempMeds Mexico, Media Coverage
Dr. Stuart Titus sat down with Everett Jolly of Uptick Newswire this week to discuss the ever increasing momentum driving marijuana legalization and the growth of the cannabis industry. Dr. Titus began the interview relaying recent accomplishments by Medical...
by adminAdrianRamirez | Jan 10, 2017 | Axim Biotechnologies, Press Releases
NEW YORK, Jan 10, 2017 — AXIM Biotechnologies, Inc. (AXIM Biotech) AXIM, +23.30% a world leader in cannabinoid research and development, today announced that George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM Biotech, is meeting with business...
by adminAdrianRamirez | Jan 9, 2017 | Axim Biotechnologies, Press Releases
AXIM Biotechnologies Announces Positive Pharmacokinetic (PK) Data Results on Proprietary Delivery Method for Cannabinoids in Chewing Gum SAN DIEGO, CA — (Marketwired) — 01/09/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first-ever publicly traded...
by adminAdrianRamirez | Jan 6, 2017 | Axim Biotechnologies, Press Releases
SAN DIEGO, CA — (Marketwired) — 01/06/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first publicly traded cannabis company in the United States, today announced that the Company was featured in a recent High Times article, “10 Largest...
by adminAdrianRamirez | Jan 4, 2017 | Axim Biotechnologies, Press Releases
NEW YORK – Jan. 04, 2017 – AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, and gears up for clinical trial on alleviating...